EIN 47-2589708

Amyloidosis Research Consortium

IRS 501(c) type
501(c)(3)
Num. employees
17
City
Year formed
2015
Most recent tax filings
2022-12-01
Description
Amyloidosis Research Consortium accelerates the development of advanced diagnostic tools and effective treatments for systemic amyloidosis through collaboration and innovation. ARC's patient and healthcare professional programs educate physicians, tailor information to suit the patient's needs, and better match them to treatment centers, care, and clinical trials. ARC has carried out research to understand the barriers and pathways to early diagnosis and developed targeted solutions. ARC raises awareness and provides physician education on the signs of amyloidosis.
Total revenues
$2,260,256
2022
Total expenses
$2,129,932
2022
Total assets
$2,516,230
2022
Num. employees
17
2022

Program areas at Amyloidosis Research Consortium

Research programs:arc has been working on a number of Research initiatives including datasharing, and patient experience studies. Arc has also developed an appointment companion tool that supports patients throughout their treatment journey. The anonymized aggregated data provides valuable real world incites. Arc is developing a patient reported outcomes tool for use in clinical practice.
Healthcare professional education:arc has carried out Research to understand the barriers and pathways to early diagnosis. From this Research, arc developed and implement targeted solutions. Arc raises awareness and provides physician education on the signs, symptoms, and care of Amyloidosis to raise the level of suspicion, improve the speed of diagnosis, and standards of care. Arc held a masterclass for physicians and nurses in dallas, tx focused on addressing the challenges of accurate diagnosis and managing care. Arc has published peer reviewed consensus guidelines defining pathway for suspicion and diagnosis with a focus on cardiology and general practice. Arc sponsored a satellite symposium at the hfsa conference on the diagnosis and treatment of cardiac Amyloidosis.
Awareness, educational programs and advocacy:arc's patient and healthcare professional programs educate physicians and tailor information to suit the patient's needs and are successfully matching them to better treatment centers, care, and clinical trials. Arc's patient advisory board are instrumental in defining and prioritizing arc's patient programs. Arc's patient support specialist provides information and guidance for patients throughout their journey. Arc also maintains a comprehensive website with the latest information and news about Amyloidosis. Arc's unique Amyloidosis pathfinder tool supports patients in finding and evaluating treatment centers and matching them with clinical trials. This tool has been further enhanced to support patients with telehealth visits and virtual care during the pandemic. Arc also hosts arc talks, a regular patient educational webinar series covering a range of important topics. Arc has developed booklets, and handouts to provide patients with in depth information on Amyloidosis related topics.

Grants made by Amyloidosis Research Consortium

GranteeGrant descriptionAmount
Heart Failure Society of America (HFSA)To Support A Satellite Symposium on Cardiac Amyloidosis$75,640

Who funds Amyloidosis Research Consortium

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Schwab Charitable FundHealth$10,250
Vanguard Charitable Endowment ProgramFor Recipient's Exempt Purpose$10,000
American Online Giving FoundationGeneral Support$6,451
...and 3 more grants received

Personnel at Amyloidosis Research Consortium

NameTitleCompensation
Isabelle LousadaChief Executive Officer and Clerk$174,102
Kristen HsuExecutive Director of Clinical Research$125,022
Vanessa BoulangerDirector of Patient Engagement$131,888
Sarah Cairns-SmithChair$0
Jason ShoreTreasurer$0
...and 1 more key personnel

Financials for Amyloidosis Research Consortium

RevenuesFYE 12/2022
Total grants, contributions, etc.$2,219,649
Program services$0
Investment income and dividends$38,694
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$1,913
Total revenues$2,260,256

Form 990s for Amyloidosis Research Consortium

Fiscal year endingDate received by IRSFormPDF link
2022-122023-09-13990View PDF
2021-122022-11-15990View PDF
2020-122021-05-26990View PDF
2019-122021-02-09990View PDF
2018-122020-01-10990View PDF
...and 3 more Form 990s
Data update history
October 25, 2023
Posted financials
Added Form 990 for fiscal year 2022
October 25, 2023
Updated personnel
Identified 1 new personnel
October 22, 2023
Used new vendors
Identified 3 new vendors, including , , and
July 17, 2023
Posted financials
Added Form 990 for fiscal year 2021
May 22, 2023
Received grants
Identified 1 new grant, including a grant for $55,000 from The Chip Miller Charitable Foundation
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
Health
Characteristics
Conducts researchLobbyingNational levelTax deductible donationsAccepts online donations
General information
Address
320 Nevada St Suite 210
Newton, MA 02460
Metro area
Boston-Cambridge-Newton, MA-NH
County
Middlesex County, MA
Website URL
arci.org/ 
Phone
(617) 899-8810
IRS details
EIN
47-2589708
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2015
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H90: Medical Specialty Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
May Not Operate or Solicit for Charitable Purposes
Charity Registration status
Delinquent
FTB status revoked
Not revoked
AG Registration Number
CT0230056
FTB Entity ID
None yet
AB 488 data last updated ("as-of") date
2024-10-16
Free account sign-up

Want updates when Amyloidosis Research Consortium has new information, or want to find more organizations like Amyloidosis Research Consortium?

Create free Cause IQ account